HC2 Completes Sale of Pansend Life Sciences Portfolio Company BeneVir Biopharm to Janssen Biotech, Inc. for Up to $1.04 Billion

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

HC2 Holdings Adopts Tax Benefits Preservation Plan to Protect Tax Attributes and Stockholder Value
HC2 Holdings Announces Name Change to INNOVATE Expected to be Effective September 20, 2021
HC2 Holdings Portfolio Company DBM Global Inc. to Pay Cash Dividend
DBM Global to Pay Cash Dividend
$1.6 billion DBM Backlog Highlights HC2 Holdings Second Quarter 2021 Results
HC2 Holdings to Report Second Quarter 2021 Results on August 6
HC2 Holdings Provides $15 Million Series C Investment to Portfolio Company R2 Technologies
HC2 Holdings, Inc. Announces New Name, INNOVATE Corp.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.